Zolmitriptan (Zomig Rapimelt, Zomig) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 24, 2026
Some Zolmitriptan products are in shortage in Canada (10 of 28 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jan 3, 2028.
A triptan used to relieve migraine attacks once they have started.
Products affected
10 / 28
In shortage since
Oct 14, 2016
Est. full return
Jan 3, 2028
Reports on file
77
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
DIN 02428474 · since Jun 27, 2017, no end estimate · Disruption of the manufacture of the drug.
Active shortage
MAR-ZOLMITRIPTAN
2.5MG · TABLET · MARCAN PHARMACEUTICALS INC
DIN 02399458 · since Apr 1, 2017, no end estimate · Delay in shipping of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Zolmitriptan is currently affected by 10 active shortage reports filed with Health Canada by SANDOZ CANADA INCORPORATED, SANIS HEALTH INC, TEVA CANADA LIMITED, JAMP PHARMA CORPORATION and 3 others.
The reported causes are: disruption of the manufacture of the drug; delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Zolmitriptan is classified under “ANTIMIGRAINE PREPARATIONS” (ATC N02CC).
Recent changes
Jul 24, 2026
Shortage resolved
Common questions
What is Zolmitriptan used for?
A triptan used to relieve migraine attacks once they have started.
When will Zolmitriptan be back in stock in Canada?
The latest manufacturer estimate is Jan 3, 2028. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Zolmitriptan in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.